Clinical Trials
50 trialsLong-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
Adicet Therapeutics
Study of CAR-T Therapy in Older Patients
Memorial Sloan Kettering Cancer Center
Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PERSIST
AvenCell Therapeutics, Inc.
LTFS
Caribou Biosciences, Inc.
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Children's Hospital Medical Center, Cincinnati
REFRACT-LyMA
Nantes University Hospital
CS22-03
AIDS Malignancy Consortium
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Medical College of Wisconsin
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Memorial Sloan Kettering Cancer Center
Family Study of Lymphoproliferative Disorders
Mayo Clinic
Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma
Beijing GoBroad Hospital
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
AKI CAR
Hospices Civils de Lyon
LBDGCréfract
Grand Hôpital de Charleroi
Systemic Inflammatory Markers in B-cell Neoplasm
Assiut University
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
National Research Center for Hematology, Russia
HMvax-Regist
Wake Forest University Health Sciences
A Real-World Study on Extranodal Lymphoma
Ruijin Hospital
CMV CAR-T
Assistance Publique - Hôpitaux de Paris
GLOFTST
The First Affiliated Hospital of Soochow University
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Instituto de Investigación Biomédica de Salamanca
Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
Gruppo Italiano Malattie EMatologiche dell'Adulto
Relmacabtagene Autoleucel in Hematologic Malignancies
Shanghai Ming Ju Biotechnology Co., Ltd.
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
Peking University People's Hospital
FLORA
Regeneron Pharmaceuticals
Obinutuzumab in Chinese Real-world Patients With iNHL
Affiliated Hospital of Nantong University
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Children's Oncology Group
Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies
Mayo Clinic
Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers
Sociedad de Lucha Contra el Cáncer del Ecuador
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
National Institutes of Health Clinical Center (CC)
ADAMANTIUS
The Lymphoma Academic Research Organisation
MUSCLE
UMC Utrecht
The Clinical Implications of Immune Checkpoint Pathways in PCNSL
National Taiwan University Hospital
Long-term Registry of Patients Treated With Loncastuximab Tesirine
ADC Therapeutics S.A.
AEDV Registry of Primary Cutaneous Lymphoma
Fundación Academia Española de Dermatología
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
University Hospital, Montpellier
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
Cogent Biosciences, Inc.
LYMPHO-Cov-2
Versailles Hospital
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Jonsson Comprehensive Cancer Center
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
University Hospital Southampton NHS Foundation Trust
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
Institut Paoli-Calmettes
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
Yonsei University
Does CMV Induced Changes in NK Lymphocyte Biology Influence the Effectiveness of Antibody Therapy Used to Treat B Cell Lymphoproliferative Diseases?
Ottawa Hospital Research Institute
Genetic Studies of X-linked Lymphoproliferative Disease
National Institutes of Health Clinical Center (CC)
Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT
A.O.U. Città della Salute e della Scienza
Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Assuta Medical Center
Monitor-GCSF
Sandoz
ProDLBCL
Fondazione Italiana Linfomi - ETS